Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Deficit (Tables)

v3.22.2.2
Shareholders' Deficit (Tables)
6 Months Ended
Jun. 30, 2022
Stockholders' Equity Note [Abstract]
Schedule of activity related to non-vested shares
Number of
Non-Vested
Shares
Weighted
Average
Grant Date
Fair Value
Non-vested, December 31, 2021 14,270,120 $ 0.14
Granted 500,000 0.028
Forfeited
-
-
Shares vested (800,000 ) (0.028 )
Non-vested, June 30, 2022 13,970,120 $ 0.14

Schedule of stock option activities
Number of
Options
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Term (Years)
Aggregate
Intrinsic
Value
Balance Outstanding, December 31, 2021 8,445,698 $ 0.40
Exercised
-
-
-
-
Balance Outstanding, June 30, 2022 8,445,698 $ 0.40 3.94 $ 0
Exercisable, June 30, 2022 8,445,698 $ 0.40 3.94 $ 0

Schedule of warrant activities
Number of
Warrants
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Term (Years)
Aggregate
Intrinsic
Value
Balance Outstanding December 31, 2021 17,500,000 $ 0.05 4.67 $
-
Granted 33,000,000 0.025
-
-
Cancelled (16,500,000 ) 0.05
-
-
Balance Outstanding June 30, 2022 34,000,000 $ 0.027 4.24 $
-
Exercisable, June 30, 2022 34,000,000 $ 0.027 4.24 $
-